|
Peptides
MADD Peptide
Background
MADD (C-Terminus) Peptide
Location
19 amino acids near the carboxy terminus of human MADD.
Application
MADD peptide is used for blocking the activity of Anti-MADD (Cat. No. 1150). Incubating the peptide with equal volume of antibody for 30 min at 37˚C usually completely blocks the antibody activity in Western blotting.
Tested Application
Bl
Buffer
PBS containing 0.02% sodium azide
Storage
MADD peptide is supplied as 200 μg/ml, 50 μg/vial, in PBS pH7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide. Store at -20˚C, stable for one year.
Species Reactivity
n/a
Species
H
Short Description
(CT) MADD peptide
This product belongs to the following categories:
Related Products
References- Milbrandt J, de Sauvage FJ, Fahrner TJ, et al. Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron 1998;20:245-253.
- Nomeclature Committee. Nomeclature of GPI-linked receptors for the GDNF ligand family. GFRa. Neuron 1997: 19:485.
- Jing S. Yu Y, Fang M, Hu Z, Holst PL, Boone T, Delaney J. Schultz H, Zhou R, Fox GM. GFRα-2 and GFRα-3 are two new receptors for ligands of the DGNF family. J Biol Chem 1997; 272:33111-33117
- Baloh RH, Gorodinsky A, Golden JP, Tansey MG, Keck CL, Popescu NC, Johnson EM Jr, Milbrandt J. GFRα3 is an orphan member of the GDNF/neurturin/persephin receptor family. Proc Natl Acad Sci USA 1998;95:5801-5806.
Datasheet 0801-W
|
|
